zepbound novo nordisk - Search News

Order byBest matchMost fresh

Novo Nordisk, Wegovy and Zepbound

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.

Continue reading

· 1d · on MSN

· 1d · on MSN

Lilly’s Zepbound Trims More Belly Fat Than Novo’s Wegovy

TipRanks on MSN · 1d

Eli Lilly’s Zepbound Defeats Novo Nordisk’s Wegovy Once Again

First head-to-head trial found Zepbound beats Wegovy for weight loss

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

Continue reading

New study compares Wegovy and Zepbound for the first time

Study finds Zepbound may help people lose more weight than Wegovy

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Participants who took Eli Lilly’s tirzepatide, which is sold as Zepbound, lost 50 pounds on average, while those using Novo Nordisk’s semaglutide, also known as Wegovy, lost an average of 33 pounds.

Continue reading

Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy

Here’s how much extra weight is lost with Zepbound over Wegovy

19h

Zepbound trims more belly fat than Wegovy, study shows

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the rival medicines.